Immunovant Investor Webcast to review results from its Phase 3 study of batoclimab in MG and initial results from its Phase 2b study in CIDP
| DATE: | March 19, 2025 |
|---|---|
| TIME: | 8:00 AM EDT |
| LOCATION: | Virtual |
About The Event
Details to follow.
| DATE: | March 19, 2025 |
|---|---|
| TIME: | 8:00 AM EDT |
| LOCATION: | Virtual |
Details to follow.